<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04971382</url>
  </required_header>
  <id_info>
    <org_study_id>OMD2021-3-</org_study_id>
    <nct_id>NCT04971382</nct_id>
  </id_info>
  <brief_title>Alveolar Ridge Augmentation With Curcumin Combined With Xenograft</brief_title>
  <official_title>Alveolar Ridge Augmentation With Curcumin Combined With Xenograft After Piezoelectric Alveolar Ridge Splitting Surgery (A Randomized Controlled Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study was performed to investigate the effect of curcumin on the osteogenic differentiation&#xD;
      of human periodontal ligament stem cells (hPDLSCs) and its underlying potential mechanism.&#xD;
      The Results was that Curcumin at an appropriate concentration had no cytotoxicity and could&#xD;
      promote osteogenic differentiation of the hPDLSCs&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be selected from the outpatient clinic of Oral Medicine, Periodontology and&#xD;
      Oral diagnosis Department, Faculty of Dentistry, Ain Shams University. The purpose of the&#xD;
      study will be explained to all patients and an informed consent will be signed before the&#xD;
      conduction of the study .The faculty research ethics committee will review the proposal.&#xD;
&#xD;
      The study will be conducted in the form of Patient Intervention Comparative Outcome (PICO)&#xD;
      question (Patient &quot;P&quot;, Intervention &quot;I&quot;, Comparative &quot;C&quot;, Outcome &quot;O&quot;). (Stone 2002) &quot;P&quot;:&#xD;
      Patient in the study will have enough alveolar ridge height ,suffering from missing from 1 to&#xD;
      3 upper maxillary anterior and /or premolar with insufficient alveolar ridge buccolingual&#xD;
      (BL) width that interfere with conventional straight forward implant placement. The minimum&#xD;
      BL width included in the study will be 4 mm. &quot;I&quot;: Ridge splitting with interposition grafting&#xD;
      with curcumin and particulate xenograft grafting. &quot;C&quot;:Alveolar ridge splitting with&#xD;
      interposition grafting with use of particulate xenograft alone without curcumin .&#xD;
      &quot;O&quot;:Clinical and radiographic outcome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical outcome</measure>
    <time_frame>change from baseline at 6 months</time_frame>
    <description>Assessment the gain in alveolar ridge buccolingual width</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stability</measure>
    <time_frame>&quot;through study completion, an average of 1 year</time_frame>
    <description>Assessment of the primary implant stability Quotient in the regenerated bone</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Horizontal Alveolar Bone Loss</condition>
  <arm_group>
    <arm_group_label>curcumin combined with particulate xenograft.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Curcumin will be used in combination with xenograft after ridge splitting surgery&#xD;
Curcumin is widely used in medicine due to medicinal properties, cost-effectiveness, and simple extraction from a turmeric plant that grows in different regions in the world. Recent evidences have shown that curcumin possesses multiple biological activities and pharmacological properties including anti-inflammation , antioxidation , anticancer , antimicrobial , and free radical scavenger effects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alveolar ridge splitting with use of particulate xenograft alone.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>xenograft will be used alone after ridge splitting</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Curcumin</intervention_name>
    <description>Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) or diferuloylmethane is an important bioactive constituent and hydrophobic polyphenol that isolated from the rhizome of the turmeric plant (Curcuma longa) . Curcumin will be used in combination with xenograft after ridge splitting surgery</description>
    <arm_group_label>alveolar ridge splitting with use of particulate xenograft alone.</arm_group_label>
    <arm_group_label>curcumin combined with particulate xenograft.</arm_group_label>
    <other_name>Curcumin (Curcuma longa)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female with age range 25-45 years.&#xD;
&#xD;
          -  Patient with enough alveolar ridge height, suffering from missing single or multiple&#xD;
             maxillary anterior and /or premolar with insufficient alveolar ridge buccolingual (BL)&#xD;
             width that interfere with conventional straight forward implant placement. The minimum&#xD;
             BL width included in the study will be 4-5 mm to facilitate ridge splitting and&#xD;
             expansion.&#xD;
&#xD;
          -  Systemically free from any diseases as evidenced by Burket's oral medicine health&#xD;
             history questionnaire.&#xD;
&#xD;
          -  Patient available during follow up periods.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers.&#xD;
&#xD;
          -  Pregnant and breast feeding females.&#xD;
&#xD;
          -  Patient unwilling to comply to oral hygienic instructions.&#xD;
&#xD;
          -  Patients under any medication or medical condition that affect the bone quality.&#xD;
&#xD;
          -  Vulnerable groups. (e.g decisions impaired individual).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hala A Abuelela, professor</last_name>
    <role>Study Director</role>
    <affiliation>faculty of dentistry . Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>yasmine G Elbohy, Ass.lecturer</last_name>
    <phone>01283881604</phone>
    <email>yasmingamal@dent.asu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Amr, Ass.professor</last_name>
    <phone>01222243314</phone>
    <email>hmedmr@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>faculty of dentistry Ain shams university</name>
      <address>
        <city>Cairo</city>
        <zip>11566</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>hala abuelela, professor</last_name>
      <phone>01002500182</phone>
      <email>dr.halaabuelela@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Yasmine Gamal</investigator_full_name>
    <investigator_title>Ass.lecturer of oral medicine and periodontology</investigator_title>
  </responsible_party>
  <keyword>curcumin</keyword>
  <keyword>xenograft</keyword>
  <keyword>Piezoelectric</keyword>
  <keyword>Alveolar Ridge Splitting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alveolar Bone Loss</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

